Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity. / Ngo, Tony; Stephens, Bryan S; Gustavsson, Martin; Holden, Lauren G; Abagyan, Ruben; Handel, Tracy M; Kufareva, Irina.

I: PLOS Biology, Bind 18, Nr. 4, 04.2020, s. e3000656.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Ngo, T, Stephens, BS, Gustavsson, M, Holden, LG, Abagyan, R, Handel, TM & Kufareva, I 2020, 'Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity', PLOS Biology, bind 18, nr. 4, s. e3000656. https://doi.org/10.1371/journal.pbio.3000656

APA

Ngo, T., Stephens, B. S., Gustavsson, M., Holden, L. G., Abagyan, R., Handel, T. M., & Kufareva, I. (2020). Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity. PLOS Biology, 18(4), e3000656. https://doi.org/10.1371/journal.pbio.3000656

Vancouver

Ngo T, Stephens BS, Gustavsson M, Holden LG, Abagyan R, Handel TM o.a. Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity. PLOS Biology. 2020 apr.;18(4):e3000656. https://doi.org/10.1371/journal.pbio.3000656

Author

Ngo, Tony ; Stephens, Bryan S ; Gustavsson, Martin ; Holden, Lauren G ; Abagyan, Ruben ; Handel, Tracy M ; Kufareva, Irina. / Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity. I: PLOS Biology. 2020 ; Bind 18, Nr. 4. s. e3000656.

Bibtex

@article{dd0cc7f526054570a3afb3d16aa9aeab,
title = "Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity",
abstract = "Chemokines and their receptors are orchestrators of cell migration in humans. Because dysregulation of the receptor-chemokine system leads to inflammation and cancer, both chemokines and receptors are highly sought therapeutic targets. Yet one of the barriers for their therapeutic targeting is the limited understanding of the structural principles behind receptor-chemokine recognition and selectivity. The existing structures do not include CXC subfamily complexes and lack information about the receptor distal N-termini, despite the importance of the latter in signaling, regulation, and bias. Here, we report the discovery of the geometry of the complex between full-length CXCR4, a prototypical CXC receptor and driver of cancer metastasis, and its endogenous ligand CXCL12. By comprehensive disulfide cross-linking, we establish the existence and the structure of a novel interface between the CXCR4 distal N-terminus and CXCL12 β1-strand, while also recapitulating earlier findings from nuclear magnetic resonance, modeling and crystallography of homologous receptors. A cross-linking-informed high-resolution model of the CXCR4-CXCL12 complex pinpoints the interaction determinants and reveals the occupancy of the receptor major subpocket by the CXCL12 proximal N terminus. This newly found positioning of the chemokine proximal N-terminus provides a structural explanation of CXC receptor-chemokine selectivity against other subfamilies. Our findings challenge the traditional two-site understanding of receptor-chemokine recognition, suggest the possibility of new affinity and signaling determinants, and fill a critical void on the structural map of an important class of therapeutic targets. These results will aid the rational design of selective chemokine-receptor targeting small molecules and biologics with novel pharmacology.",
keywords = "Animals, Binding Sites, Blotting, Western, Chemokine CXCL12/chemistry, Cysteine/chemistry, Disulfides/chemistry, Flow Cytometry, HEK293 Cells, Humans, Insecta/cytology, Models, Molecular, Mutation, Protein Conformation, Protein Interaction Domains and Motifs, Receptors, CXCR4/chemistry, beta-Arrestins/metabolism",
author = "Tony Ngo and Stephens, {Bryan S} and Martin Gustavsson and Holden, {Lauren G} and Ruben Abagyan and Handel, {Tracy M} and Irina Kufareva",
year = "2020",
month = apr,
doi = "10.1371/journal.pbio.3000656",
language = "English",
volume = "18",
pages = "e3000656",
journal = "PLoS Biology",
issn = "1544-9173",
publisher = "Public Library of Science",
number = "4",

}

RIS

TY - JOUR

T1 - Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity

AU - Ngo, Tony

AU - Stephens, Bryan S

AU - Gustavsson, Martin

AU - Holden, Lauren G

AU - Abagyan, Ruben

AU - Handel, Tracy M

AU - Kufareva, Irina

PY - 2020/4

Y1 - 2020/4

N2 - Chemokines and their receptors are orchestrators of cell migration in humans. Because dysregulation of the receptor-chemokine system leads to inflammation and cancer, both chemokines and receptors are highly sought therapeutic targets. Yet one of the barriers for their therapeutic targeting is the limited understanding of the structural principles behind receptor-chemokine recognition and selectivity. The existing structures do not include CXC subfamily complexes and lack information about the receptor distal N-termini, despite the importance of the latter in signaling, regulation, and bias. Here, we report the discovery of the geometry of the complex between full-length CXCR4, a prototypical CXC receptor and driver of cancer metastasis, and its endogenous ligand CXCL12. By comprehensive disulfide cross-linking, we establish the existence and the structure of a novel interface between the CXCR4 distal N-terminus and CXCL12 β1-strand, while also recapitulating earlier findings from nuclear magnetic resonance, modeling and crystallography of homologous receptors. A cross-linking-informed high-resolution model of the CXCR4-CXCL12 complex pinpoints the interaction determinants and reveals the occupancy of the receptor major subpocket by the CXCL12 proximal N terminus. This newly found positioning of the chemokine proximal N-terminus provides a structural explanation of CXC receptor-chemokine selectivity against other subfamilies. Our findings challenge the traditional two-site understanding of receptor-chemokine recognition, suggest the possibility of new affinity and signaling determinants, and fill a critical void on the structural map of an important class of therapeutic targets. These results will aid the rational design of selective chemokine-receptor targeting small molecules and biologics with novel pharmacology.

AB - Chemokines and their receptors are orchestrators of cell migration in humans. Because dysregulation of the receptor-chemokine system leads to inflammation and cancer, both chemokines and receptors are highly sought therapeutic targets. Yet one of the barriers for their therapeutic targeting is the limited understanding of the structural principles behind receptor-chemokine recognition and selectivity. The existing structures do not include CXC subfamily complexes and lack information about the receptor distal N-termini, despite the importance of the latter in signaling, regulation, and bias. Here, we report the discovery of the geometry of the complex between full-length CXCR4, a prototypical CXC receptor and driver of cancer metastasis, and its endogenous ligand CXCL12. By comprehensive disulfide cross-linking, we establish the existence and the structure of a novel interface between the CXCR4 distal N-terminus and CXCL12 β1-strand, while also recapitulating earlier findings from nuclear magnetic resonance, modeling and crystallography of homologous receptors. A cross-linking-informed high-resolution model of the CXCR4-CXCL12 complex pinpoints the interaction determinants and reveals the occupancy of the receptor major subpocket by the CXCL12 proximal N terminus. This newly found positioning of the chemokine proximal N-terminus provides a structural explanation of CXC receptor-chemokine selectivity against other subfamilies. Our findings challenge the traditional two-site understanding of receptor-chemokine recognition, suggest the possibility of new affinity and signaling determinants, and fill a critical void on the structural map of an important class of therapeutic targets. These results will aid the rational design of selective chemokine-receptor targeting small molecules and biologics with novel pharmacology.

KW - Animals

KW - Binding Sites

KW - Blotting, Western

KW - Chemokine CXCL12/chemistry

KW - Cysteine/chemistry

KW - Disulfides/chemistry

KW - Flow Cytometry

KW - HEK293 Cells

KW - Humans

KW - Insecta/cytology

KW - Models, Molecular

KW - Mutation

KW - Protein Conformation

KW - Protein Interaction Domains and Motifs

KW - Receptors, CXCR4/chemistry

KW - beta-Arrestins/metabolism

U2 - 10.1371/journal.pbio.3000656

DO - 10.1371/journal.pbio.3000656

M3 - Journal article

C2 - 32271748

VL - 18

SP - e3000656

JO - PLoS Biology

JF - PLoS Biology

SN - 1544-9173

IS - 4

ER -

ID: 329431899